Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription 06.05.2024 1 AJR Am J Roentgenol 11 Am J Cardiol 1 Am J Crit Care 3 Am J Med 2 Angiology 1 Ann Intern Med 4 Ann Thorac Surg 1 Arterioscler Thromb Vasc Biol 1 BMJ 1 Cardiovasc Res 2 Circ Cardiovasc Qual Outcomes 1 Circ Heart Fail 1 Circ J 4 Circulation 1 Clin Cardiol 9 Int J Cardiol 6 J Am Coll Cardiol 1 J Clin Invest 1 J Electrocardiol 1 J Mol Cell Cardiol 1 J Thromb Haemost 1 Mayo Clin Proc 1 N Engl J Med 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. FONG FW, Hwang S, Xu Y, Hui WHA, et al
   Prognostic Utility of Left Atrial Strain From MRI Feature Tracking in Ischemic and Nonischemic Dilated Cardiomyopathy: A Multicenter Study.
   AJR Am J Roentgenol. 2024 Feb 7. doi: 10.2214/AJR.23.30357.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. VASUDEVA R, Mehta H, Chan WC, Majmundar M, et al
   Nationwide Trends and Outcomes for Coronary Artery Bypass Grafting in End-Stage Kidney Disease and Stable Coronary Artery Disease.
   Am J Cardiol. 2024;210:37-43.
   PubMed         Abstract available
   
   
3. MOVAHED MR
   Significant Downplay and Underreporting of Adverse Events in Patients Who Underwent Percutaneous Coronary Intervention of Chronic Total Occlusions.
   Am J Cardiol. 2024;210:317.
   PubMed        
   
   
4. ANG SP, Krittanawong C, Usman MH, Iglesias J, et al
   Sex Differences in the Short and Long-term Outcomes Following Rotational Atherectomy. A Meta-analysis.
   Am J Cardiol. 2024 Mar 14:S0002-9149(24)00192.
   PubMed         Abstract available
   
   
5. BAY B, Sharma R, Roumeliotis A, Power D, et al
   Impact of Polyvascular Disease in Patients undergoing unprotected Left Main Percutaneous Coronary Intervention.
   Am J Cardiol. 2024 Apr 30:S0002-9149(24)00317.
   PubMed         Abstract available
   
   
6. MOON J, Ozaki AF, Chong A, Sud M, et al
   Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes.
   Am J Cardiol. 2024 Apr 30:S0002-9149(24)00329.
   PubMed        
   
   
7. BERBARIE RF
   Revascularizing Multivessel Coronary Artery Disease in Acute Coronary Syndromes: Choices and Questions.
   Am J Cardiol. 2024 Apr 27:S0002-9149(24)00316.
   PubMed        
   
   
8. GOKHALE KM, Chandan JS, Sainsbury C, Tino P, et al
   Using Repeated Measurements to Predict Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
   Am J Cardiol. 2024;210:133-142.
   PubMed         Abstract available
   
   
9. BHARADWAJ AS, Truesdell AG, Lemor A, Thompson JB, et al
   Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice.
   Am J Cardiol. 2024 Apr 26:S0002-9149(24)00323.
   PubMed        
   
   
10. GONZALEZ PE, Hebbe A, Hussain Y, Khera R, et al
    Real-World Experience and Outcomes with Percutaneous Coronary Intervention for Protected versus Unprotected Left Main Coronary Artery Disease: Insights from the VA CART Program.
    Am J Cardiol. 2024 Apr 25:S0002-9149(24)00320.
    PubMed         Abstract available
    
    
11. EMORI H, Shiono Y, Kuriyama N, Honda Y, et al
    Impact of periprocedural myocardial injury on long-term outcomes after percutaneous coronary intervention requiring atherectomy.
    Am J Cardiol. 2024 Apr 25:S0002-9149(24)00318.
    PubMed         Abstract available
    
    
12. BALLOTTA A
    Robotic Assisted Hybrid Coronary Revascularization.
    Am J Cardiol. 2024 Apr 24:S0002-9149(24)00282.
    PubMed        
    
    

    
    Am J Crit Care

13. DZIKOWICZ DJ, Suba S, Carey MG
    Cardiac Arrhythmias After Coronary Artery Bypass Graft Surgery.
    Am J Crit Care. 2024;33:235-236.
    PubMed        
    
    

    
    Am J Med

14. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available
    
    
15. KAWADA T
    Depression, Cardiovascular Disease, and Mortality.
    Am J Med. 2024;137:e96.
    PubMed        
    
    
16. SORENSEN NA, Fakhri Y, Gossling A, Neumann JT, et al
    Impact of quantitative ST-T analysis in patients with suspected myocardial infarction presenting with right bundle branch block.
    Am J Med. 2024 Apr 24:S0002-9343(24)00244-4. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available
    
    

    
    Angiology

17. LIU T, Li T, Pan J
    Naples Prognostic Score as a Novel Biomarker of Prognosis in Patients With ST-Segment Elevation Myocardial Infarction.
    Angiology. 2024 Apr 28:33197241251888. doi: 10.1177/00033197241251888.
    PubMed        
    
    
18. LU Y, Ni W, Qu X, Chen C, et al
    Spironolactone for Preventing Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease.
    Angiology. 2024 Apr 28:33197241251889. doi: 10.1177/00033197241251889.
    PubMed         Abstract available
    
    

    
    Ann Intern Med

19. YEN FS, Hwu CM, Liu JS, Wu YL, et al
    Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-1874.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

20. HALUB M, Soltesz EG, Tong MZ, Bakaeen FG, et al
    Early Mechanical Support and Revascularization in Ischemic Cardiomyopathy: Premature or Prudent?
    Ann Thorac Surg. 2024;117:940-941.
    PubMed        
    
    
21. SINGH SK, Vinogradsky A, Kirschner M, Sun J, et al
    Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy.
    Ann Thorac Surg. 2024;117:932-939.
    PubMed         Abstract available
    
    
22. HOSSEINI M, Griffeth EM, Schaff HV, Klompas AM, et al
    Analysis of Anemia, Transfusions, and CABG Outcomes in The Society of Thoracic Surgeons National Database.
    Ann Thorac Surg. 2024;117:1053-1060.
    PubMed         Abstract available
    
    
23. WILLARD R, Scheinerman J, Pupovac S, Patel NC, et al
    The Current State of Hybrid Coronary Revascularization.
    Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

24. BELIARD S, Saheb S, Litzler-Renault S, Vimont A, et al
    Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 2. doi: 10.1161/ATVBAHA.123.320609.
    PubMed         Abstract available
    
    

    
    BMJ

25. LI Z, Min XW, He PG, Zhang CH, et al
    Chest pain with diffuse ST segment elevation.
    BMJ. 2024;385:e078403.
    PubMed        
    
    

    
    Cardiovasc Res

26. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

27. RUSSO RG, Danaei G
    Can Observational Data and Target Trial Emulation Inform Cardiovascular Disease Prevention and Management Guidelines?
    Circ Cardiovasc Qual Outcomes. 2024 Apr 29:e010979.
    PubMed        
    
    
28. FAYOL A, Schiele F, Ferrieres J, Puymirat E, et al
    Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults.
    Circ Cardiovasc Qual Outcomes. 2024 Apr 29:e010685.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

29. DUTZMANN J, Kefalianakis Z, Kahles F, Daniel JM, et al
    Intermittent Fasting After ST-Segment-Elevation Myocardial Infarction Improves Left Ventricular Function: The Randomized Controlled INTERFAST-MI Trial.
    Circ Heart Fail. 2024 May 2:e010936. doi: 10.1161/CIRCHEARTFAILURE.123.010936.
    PubMed         Abstract available
    
    

    
    Circ J

30. HOSHI T, Sawano M, Kohsaka S, Ishii H, et al
    Impact of Sex Differences on Clinical Outcomes in Patients Following Primary Revascularization for Acute Myocardial Infarction?- Insights From the Japanese Nationwide Registry.
    Circ J. 2024 Apr 27. doi: 10.1253/circj.CJ-23-0966.
    PubMed         Abstract available
    
    

    
    Circulation

31. SOLOMON CG, Landrigan PJ
    Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
    Circulation. 2024;149:1400-1401.
    PubMed        
    
    
32. ZAMAN S, Edwards NC, Chew DP
    Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Circulation. 2024;149:1402-1404.
    PubMed        
    
    
33. KELHAM M, Mathur A, Jones DA
    Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1133.
    PubMed        
    
    
34. APOSTOLOS A, Karamasis GV, Tsigkas G
    Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1132.
    PubMed        
    
    

    
    Clin Cardiol

35. LI H, Liu X, Wang X, Yang Q, et al
    Relationship between Thyroid Feedback Quantile-based Index and cardiovascular diseases in a population with normal thyroid function: Evidence from the National Health and Nutrition Examination Survey 2007-2012.
    Clin Cardiol. 2024;47:e24271.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

36. TOFTHOLM MH, Hojstrup S, Talleruphuus U, Marner L, et al
    82-rubidium positron emission tomography determined myocardial flow reserve and outcomes following cardiac revascularisation - A multicentre registry study.
    Int J Cardiol. 2024;405:131865.
    PubMed         Abstract available
    
    
37. MUTLU D, Rempakos A, Alexandrou M, Al-Ogaili A, et al
    Emergency coronary artery bypass surgery after chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2024;405:131931.
    PubMed         Abstract available
    
    
38. SCHINDLER TH, Sadhu J
    Moving towards PET determined coronary flow capacity in outcome prediction after coronary revascularization?
    Int J Cardiol. 2024;405:131921.
    PubMed        
    
    
39. VAN DEN BROEK WWA, Gimbel ME, Hermanides RS, Runnett C, et al
    The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
    Int J Cardiol. 2024 Mar 7:131940. doi: 10.1016/j.ijcard.2024.131940.
    PubMed         Abstract available
    
    
40. IN KIM Y, Roh JH, Kweon J, Kwon H, et al
    Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning.
    Int J Cardiol. 2024;405:131945.
    PubMed         Abstract available
    
    
41. LI C, Deng C, Shi B, Zhao R, et al
    Thin-cap fibroatheroma in acute coronary syndrome: Implication for intravascular imaging assessment.
    Int J Cardiol. 2024;405:131965.
    PubMed         Abstract available
    
    
42. BEERKENS FJ, Kucuk IT, van Veelen A, de Lind van Wijngaarden RAF, et al
    Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.
    Int J Cardiol. 2024;405:131974.
    PubMed         Abstract available
    
    
43. JIN Y, Shen L, Ye R, Zhou M, et al
    Development and validation of a novel score for predicting perioperative major adverse cardiovascular events in patients with stable coronary artery disease undergoing noncardiac surgery.
    Int J Cardiol. 2024;405:131982.
    PubMed         Abstract available
    
    
44. JHAND AS, Abusnina W, Tak HJ, Ahmed A, et al
    Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.
    Int J Cardiol. 2024 Apr 30:132111. doi: 10.1016/j.ijcard.2024.132111.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

45. JAGER R, Hoke M, Mayer FJ, Boden S, et al
    Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    J Am Coll Cardiol. 2024;83:1717-1727.
    PubMed         Abstract available
    
    
46. NATARAJAN P, Bellomo TR
    Clonal Hematopoiesis Among Patients With Asymptomatic Carotid Stenosis Compounds Risk of Cardiovascular Death.
    J Am Coll Cardiol. 2024;83:1728-1730.
    PubMed        
    
    
47. YU MM, Wang ML, Wang JJ, Lin BL, et al
    Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque.
    J Am Coll Cardiol. 2024;83:1743-1755.
    PubMed         Abstract available
    
    
48. BLANKSTEIN R, Shiyovich A
    Can Plaque Imaging Improve Risk Assessment Among Individuals With Elevated Lp(a)?
    J Am Coll Cardiol. 2024;83:1756-1759.
    PubMed        
    
    
49. GOLDSTEIN JA, Lerakis S, Moreno PR
    Right Ventricular Myocardial Infarction-A Tale of Two Ventricles: JACC Focus Seminar 1/5.
    J Am Coll Cardiol. 2024;83:1779-1798.
    PubMed         Abstract available
    
    
50. ESTEVEZ-LOUREIRO R, Lorusso R, Taramasso M, Torregrossa G, et al
    Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5.
    J Am Coll Cardiol. 2024;83:1799-1817.
    PubMed         Abstract available
    
    

    
    J Clin Invest

51. FAILER T, Amponsah-Offeh M, Neuwirth A, Kourtzelis I, et al
    Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.
    J Clin Invest. 2024;134:e181599.
    PubMed        
    
    

    
    J Electrocardiol

52. DE ALENCAR JN, Amorim EF, Scheffer MK, Felicioni SP, et al
    Poor evidence for poor R wave progression in coronary disease: A scoping review.
    J Electrocardiol. 2024;84:145-150.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

53. SUN H, Wang X, Pratt RE, Dzau VJ, et al
    C166 EVs potentiate miR cardiac reprogramming via miR-148a-3p.
    J Mol Cell Cardiol. 2024;190:48-61.
    PubMed         Abstract available
    
    

    
    J Thromb Haemost

54. POCOCK SJ, Owen R, Gregson J, Mt-Isa S, et al
    Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case study.
    J Thromb Haemost. 2024;22:1399-1409.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

55. TALMOR-BARKAN Y, Yu J, Yacovzada NS, Pravda NS, et al
    Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.
    Mayo Clin Proc. 2024 Apr 26:S0025-6196(24)00028.
    PubMed         Abstract available
    
    

    
    N Engl J Med

56. GRINSPOON SK, Ribaudo HJ, Douglas PS
    Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection.
    N Engl J Med. 2024;390:1626-1628.
    PubMed        
    
    

    
    PLoS One

57. STROBL K, Irfan SA, Masood H, Latif N, et al
    Association between PM10 exposure and risk of myocardial infarction in adults: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0301374.
    PubMed         Abstract available
    
    
58. DEWI PEN, Sunantiwat M, Thavorncharoensap M, Youngkong S, et al
    Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study.
    PLoS One. 2024;19:e0302320.
    PubMed         Abstract available
    
    
59. ZHAO X, Yang F, Wu H, Fan Z, et al
    Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis.
    PLoS One. 2024;19:e0302650.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.